Press release
Phosphodiesterase Enzyme (PDE) Inhibitors Market Opportunity Analysis, 2018-2026
Phosphodiesterase are a diverse family of enzymes (11 isoenzymes) that play a key role in regulating intracellular levels of secondary messengers - cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate. These enzymes identified to be pharmacologically active in the 1950s, hydrolyses cyclic nucleotides to treat various diseases such as cardiovascular, respiratory and erectile dysfunction. Distinct distribution of all the types of isoenzymes has provided possibilities for selective target therapies.Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/172
The global phosphodiesterase enzyme inhibitors market can be better analyzed by classifying it into two classes as selective phosphodiesterase enzyme inhibitors and non-selective phosphodiesterase enzyme inhibitors. Theophylline and papaverineare the two most commonly used non-selective phosphodiesterase enzyme inhibitors for treating a range of diseases (bronchodilation, cardiac disorder, etc.). Advent of selective phosphodiesterase enzyme inhibitors has made a great impact in the medical treatment sector. Increasing understanding of the individual PDE isoforms has and will result in the emergence of better therapeutic drugs. Viagra (Sildenafil) is the best example to substantiate the success and impact of PDE inhibitors.
Increasing product developments to further improvise the phosphodiesterase enzyme inhibitors market outlook
The global phosphodiesterase enzyme inhibitors market has recently gained traction on account of the blockbuster PDE 5 inhibitor brands, Viagra and Cialis. This has also encouraged pharmaceutical companies to research on other PDE inhibitor class. In addition, research on extended use of approved PDE inhibitors is anticipated to benefit the drug in long term and contribute to the increasing revenues of PDE inhibitors market.
Researchers from the John Hopkin University reviewed the trials of PDE-5 inhibitors in pediatric patients with pulmonary hypertension. The researchers concluded that PDE-5 inhibitors can be safely prescribed to infants, neonates and children with primary and secondary pulmonary hypertension (2017).
Besides, PDE-5 inhibitor sildenafil accidently developed for treating angina, was also found to be effective in erectile dysfunction and now is observed to benefit heart attack patients. Researchers at Karolinska Institutet, Sweden reported in March 2017 that PDE-5 inhibitors prescribed for erectile dysfunction can lower the risk of death of hospitalization for heart failure in men who have had one heart attack in their lifetime.
Pfizer, Inc. received FDA approval for its PDE-4 inhibitor Crisaborole (Eucris) in December 2016 for the treatment of mild to moderate atopic dermatitis. Eucrisa the first non-steroidal topical monotherapy for skin disorder.
Many such product developments would be augmenting the global PDE inhibitors market growth in near future.
Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/172
New products are primarily targeted in develop economies like North America, Europe and Japan. However, product approval in emerging nations such as India, China, Brazil, Russia, Argentina, and Indonesia would potentially favorable for the market players. Increasing healthcare expenditure and large target population base would support the growth of PDE inhibitors market in these nations. However, market players need to be cautious about uncertain regulatory conditions favoring the economic status and healthcare need of the large patient population.
Some of the key players operating in the global phosphodiesterase enzyme inhibitors market include Pfizer, Inc., AstraZeneca plc, Bayer AG, Eli Lilly & Company, Celgene Corporation, Mist Pharmaceuticals.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phosphodiesterase Enzyme (PDE) Inhibitors Market Opportunity Analysis, 2018-2026 here
News-ID: 1185949 • Views: …
More Releases from Coherent Market Insights

Commercial Drones Market Outlook, Trend Analysis, Current Growth, Future Scope a …
The Commercial Drones Market is estimated to be valued at USD 25.35 Bn in 2025 and is expected to reach USD 62.30 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.7% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Commercial Drones Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of…

Aerospace Parts Manufacturing Market Booming Worldwide Size: 2025, Regional Grow …
The aerospace parts manufacturing market is estimated to be valued at USD 979.43 Bn in 2025 and is expected to reach USD 1,533.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Aerospace Parts Manufacturing Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…

Global Deep Cycle Battery , Market Share 2025 Global Key Findings, Industry Dema …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Deep Cycle Battery , Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides…

Global ASIC Chip Market Size 2025 Emerging Demands, Share, Trends, Futuristic Op …
The ASIC chip market is estimated to be valued at USD 21.77 Bn in 2025 and is expected to reach USD 35.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "ASIC Chip Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective…
More Releases for PDE
Freyr Submits 400+ HBEL (PDE/ADE & OEL) Reports in 2024
"Freyr is pleased to announce the feat of delivering 400+ Permitted Daily Exposure (PDE) or Acceptable Daily Exposure (ADE) reports in the calendar year 2024. The submissions also included standalone Occupational Exposure Limit (OEL) reports and combined PDE/ADE and OEL reports for more than twenty-five (25) global pharmaceutical companies.
The ADE/PDE values are used in the calculation of cleaning limits in the pharmaceutical cleaning validation process. With the recommendation on the…
Phosphodiesterase (PDE) Inhibitors Market: Understanding Its Growth and Dynamics
Phosphodiesterase (PDE) inhibitors are a class of medications that play a crucial role in regulating various physiological processes by inhibiting the phosphodiesterase enzymes responsible for breaking down cyclic nucleotides. These inhibitors are widely used across multiple therapeutic areas, including cardiovascular diseases, respiratory disorders, and erectile dysfunction. With their broad applications, PDE inhibitors have become a cornerstone in modern pharmacology. This article delves into the market size, evolution, trends, growth trajectory,…
Phosphodiesterase (PDE) Inhibitors Market: Unlocking Therapeutic Potential
The Phosphodiesterase (PDE) inhibitors market is a pivotal segment in the pharmaceutical and biotechnology industry, offering promising solutions for various medical conditions. These inhibitors play a crucial role in managing cardiovascular, respiratory, and central nervous system disorders, among others. With a robust pipeline and ongoing research, the PDE inhibitors market continues to witness significant advancements, addressing unmet medical needs and improving patient outcomes.
Introduction
Phosphodiesterase inhibitors are compounds that block the action…
Freyr Completes 1500+ PDE Reports in Three (3) Years
Freyr, a leading global Regulatory solutions and services provider, is pleased to announce the feat of completing 1500+ Permissible Daily Exposure (PDE) reports. The feat has been achieved within three (3) years of the implementation of the European Medicines Agency’s (EMA’s) ‘Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/ SWP/169430/2012) across the globe for all the…
Global PDE Inhibitors Market Research Report 2015-2025
About the Global PDE Inhibitors Market Research Report 2015-2025:
Global PDE Inhibitors Market Research Report 2015-2025 is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies and strategies accordingly and gain topmost…
PDE Inhibitor Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-other-reports/pde-inhibitor-market/71843
The global market size of PDE Inhibitor is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand,…